ÂÜÀòÂÒÂ×

Robert Jan Lamers is an accomplished executive in the biotechnology and life sciences sectors, currently serving as the Chief Executive Officer of Orthros Medical since August 2020, focusing on therapeutics and diagnostics utilizing single domain antibodies. Additionally, Robert holds the position of Managing Director at Graviton Bioscience and Chondropeptix, while also being the Founder and Board Member of the Lila Foundation. Previously, Robert co-founded Complement Pharma, where Robert Jan served as Chief Executive Officer until its acquisition by Graviton Bioscience, and held executive roles at Arthrogen and Regenesance, both of which were subsequently acquired. Robert's experience also includes co-founding Investormatch and directing ventures at the Academic Medical Center and the University of Amsterdam. Robert's educational background includes a degree in Business Economics from the University of Amsterdam.